Acacia Pharma

Acacia Pharma is an England-based pharmaceutical company that develops and commercializes novel products for cancer chemotherapy.

Business Model:

Revenue: $211k

Employees: 51-200

Detailed Acacia Pharma Information

Acacia Pharma was acquired by Eagle Pharmaceuticals.
The acquisition happend on 2022-03-28.
Details of the transaction were not public

Geographic Data

Acacia Pharma headquarters map

Address: Royston Road

City: Cambridge

State: england

Zip: CB22 4QH

Country: GB

Financial Info

Stage:

debt financing

Raised Last:

$30M

Raised Total:

$64M

Metrics

1,358,977Website Global Rank

15,766Website Monthly Traffic

Twitter Followers

Description

Acacia Pharma is an England-based pharmaceutical company that develops and commercializes novel products for cancer chemotherapy.

Contact Phone:

Contact Email:

Acacia Pharma went public on 2/21/2018 on the Other

Listed Exchange:
Other

IPO Date:
2/21/2018

Ticker Symbol:
ACPH

IPO Price:
$4.4210347923157505/share

Amount Raised:
$49M

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
6/2020 Cosmo Pharmaceuticals Post-IPO Debt 25M
6/2020 Cosmo Pharmaceuticals Post-IPO Debt 0
Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research